Bone Grafts/Substitutes, Polymers, Ceramics, Growth Factors and Tissue Engineering in Orthopedics

Share Article

The use of products collectively known as "orthopedic biomaterials" represents a growing share of clinical practice in orthopedics. Current uses, products on the market, new products under development and their sales in the worldwide market are detailed in a MedMarket Diligence report that reveals opportunities for competitors.

An array of different biological and synthetic materials are commonly used in orthopedic applications to replace, augment, heal or otherwise enhance the function of musculoskeletal tissues that is damaged or deficient as a result of disease or trauma. These include bone grafts, bone graft substitutes, ceramics, polymers, growth factors and tissue engineering products and have generally been termed "biomaterials". Biomaterials are intended to interface with biological systems; they may be viable or non-viable. The category of biomaterials now generally includes biomimetic materials - synthetic constructs with compositions and properties similar to biological materials. Calcium hydroxyapatite, used as a coating on artificial hips, is a typical example; it is used as a bone replacement and facilitates attachment of an implant to living bone.

Competition in the market for biomaterials includes major orthopedic device players like Stryker, De Puy, Interpore Cross, and Smith & Nephew, but also includes a range of focused biomaterials innovators including Genzyme BioSurgery and many niche players.

The MedMarket Diligence report, "Emerging Trends, Technologies and Opportunities in the Markets for Orthopedic Biomaterials, Worldwide," details the biomaterials in use and under development for the range of orthopedic applications, presents the current and forecast worldwide market and profiles the key companies active in this market, with segmentation for the U.S., Europe, Japan and the Rest of World. The report's coverage and the complete table of contents and list of exhibits are shown at For additional details, contact Patrick Driscoll at 949-859-3401 or patrick-at-mediligence-dot-com.

About MedMarket Diligence
MedMarket Diligence provides tactical decision-making solutions on medical technology to the medical products and investment industries. The company publishes the MedMarkets newsletter, a monthly analysis of the market implications of new medical technologies, and dedicated reports on technology markets.


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Visit website